256
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Doxorubicin hydrochloride loaded nanotextured films as a novel drug delivery platform for ovarian cancer treatment

ORCID Icon, , &
Pages 1289-1301 | Received 17 Mar 2020, Accepted 11 Sep 2020, Published online: 23 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Samaneh Sepahi, Lily Kiaei, Mahmoud Kiaei & Adel Ghorani-Azam. (2023) A systematic review of emerging technologies to enhance the treatment of ovarian cancer. Pharmaceutical Development and Technology 28:7, pages 660-677.
Read now

Articles from other publishers (2)

Habib MotieGhader, Parinaz Tabrizi-Nezhadi, Mahshid Deldar Abad Paskeh, Behzad Baradaran, Ahad Mokhtarzadeh, Mehrdad Hashemi, Hossein Lanjanian, Seyed Mehdi Jazayeri, Masoud Maleki, Ehsan Khodadadi, Sajjad Nematzadeh, Farzad Kiani, Mazaher Maghsoudloo & Ali Masoudi-Nejad. (2022) Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis. Scientific Reports 12:1.
Crossref
Bifei Li, Jianhui Li, Wei Gan, Ying Tan & Qunhui Yuan. (2021) Unveiling the Molecular Dynamics in a Living Cell to the Subcellular Organelle Level Using Second-Harmonic Generation Spectroscopy and Microscopy. Analytical Chemistry 93:42, pages 14146-14152.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.